PGXIS
Pharmaceuticals - High Wycombe, England, United Kingdom
PGXIS Employees
PGXIS Details
PGXIS is a biotechnology company, founded in 2007. Our goal is to reinvigorate pharmaceutical R&D by enhanced use of genetic information, thereby ensuring that new drugs have a higher probability of successfully completing clinical trials, reaching market, providing effective therapy for patients. We maintain a virtual drug discovery model, led by our unique Taxonomy3® platform, which uses ground breaking mathematical algorithms to assist successful drug discovery & development. Alongside this we continue to offer our fee-for-service portfolio of pharmacogenomic services. Taxonomy3® utilises genetic data from patient populations, and allows us to screen for, and identify gene-gene interactions (epistasis) for specific disease states. Our experience shows that these interactions account for the ‘missing heritability' seen in genome-wide association studies (GWAS) of complex diseases. This ability allows us to better define potential drug targets which conventional research methodology will struggle to find. Equipped with the proprietary read-out from Taxonomy3®, we believe that we will be well equipped to enter the drug discovery market with innovative molecules that possess a higher probability of successful clinical development. Our intention is to license these molecules to pharmaceutical companies at the appropriate stage of drug development. PGXIS continues to provide fee-for-service genomics expertise to its customers in the following areas: • Identification and prioritisation of drug targets • Prediction of drug-associated adverse events • Prediction of drug efficacy • In vitro knockdown of genes (see http://www.cytopathfinder.com/eng/) • Strategy and implementation-based PGx consultancy Please see our web site (www.pgxis.com) for more information on any of these applications.
PGXIS Technologies
Load Balancers
Nginx
Domain Name Services
DNS.com
CSS and JavaScript Libraries
Bootstrap Framework
Other
Mobile Friendly